Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Sara L. Revolinski PharmD
Adjunct Assistant Professor
Department of School of Pharmacy Administration
Division of Administration

OFFICE ADDRESS:
Health Research Center
8701 Watertown Plank Rd
Milwaukee, WI 53226

EDUCATION:
08/30/1999 - 05/12/2006 Doctor of Pharmacy, University of Wisconsin, Madison, WI

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
06/28/2006 - 06/30/2007 PGY1 Pharmacy Residency, Froedtert Hospital, 9200 W Wisconsin Ave, Milwaukee, WI 53226

FACULTY APPOINTMENTS:
2012 - 2018 Clinical Instructor, University of Wisconsin
2013 - 2018 Clinical Instructor, Concordia University Wisconson, Mequon, WI
09/01/2016 - 06/30/2018 Clinical Assistant Professor, Medical College of Wisconsin School of Pharmacy, 8701 Watertown Plank Rd, Milwaukee, WI 53226
07/01/2018 - Present Assistant Professor, Medical College of Wisconsin School of Pharmacy, 8701 Watertown Plank Rd, Milwaukee, WI 53226

ADMINISTRATIVE APPOINTMENTS:
07/01/2018 - 06/30/2020 Director of Experiential Education, Medical College of Wisconsin School of Pharmacy, 8701 Watertown Plank Rd, Milwaukee, WI 53226
07/01/2020 - Present Director of Experiential Education and Professional Labs, Medical College of Wisconsin School of Pharmacy, 8701 Watertown Plank Rd, Milwaukee, WI 53226

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
12/2004 - 12/2006 Pharmacist and Pharmacy Intern, Walgreen Pharmacy, Milwaukee, WI
05/2006 - 05/2008 Clinical Pharmacist, Froedtert Hospital, Milwaukee, WI
07/2007 - 06/2008 Pharmacy Manager and Pharmacist, Aurora Pharmacy, Milwaukee, WI
07/2008 - 11/2011 Clinical Pharmacist, ThedaCare Appleton Medical Center, Appleton, WI
01/2012 - 08/2012 Clinical Pharmacist, Froedtert Hospital, Milwaukee, WI
09/2012 - 03/2013 Clinical Pharmacy Manager – Infectious Diseases and Pulmonary Service Lines, Froedtert Hospital, Milwaukee, WI
04/2013 - 06/2018 Antimicrobial Stewardship Coordinator, Froedtert & the Medical College of Wisconsin, Milwaukee, WI
03/2014 - 06/2018 Primary Preceptor, Residency Program, Froedtert Hospital, Milwaukee, WI
07/2018 - Present Antimicrobial Stewardship Pharmacist, Froedtert & the Medical College of Wisconsin, Milwaukee, WI

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
Board Certified Pharmacotherapy Specialist
12/30/2009
None
   
Certificates
Issued By Issue DateExpiration
Antimicrobial Stewardship Certificate
Society of Infectious Diseases Pharmacists
03/01/2015
None
    

Licensure
Number Issue DateExpiration
State of Wisconsin Pharmacy Examining Board
14712-040
None
    

AWARDS AND HONORS:
01/2014 Cubist Pharmaceuticals Antimicrobial Stewardship IIR Grant
05/2014 American Society of Health-System Pharmacists Mentored Impact Program
12/2015 American Society of Health-System Pharmacists Best Practices Award in Health-System Pharmacy
04/2016 Merck Investigator Studies Program Antimicrobial Stewardship Grant

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
12/2011 - Present American College of Clinical Pharmacy (ACCP) (Practice-Based Research Network (PBRN) Member)
12/2011 - Present American College of Clinical Pharmacy (ACCP) (ID PRN Publications Committee Member and Section Coordinator)
09/2012 - Present American Society of Health-System Pharmacists (ASHP) (Member)
07/2014 - Present American Society for Microbiology (ASM) (Member)
09/2014 - Present Society of Infectious Diseases Pharmacists (SIDP) (Member)
11/2014 - Present Greater Milwaukee College of Clinical Pharmacy (local chapter of ACCP) (Education Committee Member)
04/2015 - Present Pharmacy Society of Wisconsin (PSW) (Member)
11/2015 - 12/2018 Society for Healthcare Epidemiology of America (SHEA) (Journal Club contributor for SHEA News)
11/2015 - Present Society for Healthcare Epidemiology of America (SHEA) (Member)
11/2016 - Present Society of Infectious Diseases Pharmacists (SIDP) (Stewardship Committee, Member)
02/2017 - Present Greater Milwaukee College of Clinical Pharmacy (local chapter of ACCP) (Chair, Education Committee)
01/2018 - 12/2019 Society for Healthcare Epidemiology of America (SHEA) (Publications Committee, Journal Club Liaison)
04/2018 - 07/2018 Society for Healthcare Epidemiology of America (SHEA) (Journal Club Interim Chair)
07/2018 - Present American Association of Colleges of Pharmacy (Member)
09/2018 - Present American Association of Colleges of Pharmacy (Newsletter Committee Member)
01/2019 - Present Society for Healthcare Epidemiology of America (SHEA) (Antimicrobial Stewardship Committee)

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Regional
Perspectives in Practice Advancement: Leveraging Students as Pharmacist Extenders, American Society of Health-System Pharmacists Midyear Clinical Meeting, 12/2015
Implementing Change in Antimicrobial Stewardship Programs: Focus on Time to Effective Therapy, Asymptomatic Bacteriuria in the Emergency Department, and Pneumonia Risk Assessment, American Society of Health-System Pharmacists eLearning, 02/2016
Impact of a Rapid Diagnostic Test for MRSA in Respiratory Isolates for Critically Ill Patients, Society for Healthcare Epidemiology of America Spring Meeting, 04/2018
How a “Little” Learning Can be a Dangerous Thing: Precepting the Overconfident Learner, American Society of Health-System Pharmacists National Pharmacy Preceptor Conference, 10/2019
Clinical Case Dialogue: Managing Serious Gram-Negative Infections in the Hospital, American Society of Health System Pharmacists, eLearning Webinar, 11/2019
Turning the Tide on Serious Gram-Negative Infections in Hospitals, American Society of Health-System Pharmacists, eLearning Webinar, 11/2019
 
Local
Multiple Sclerosis: New and Emerging Therapies, Workshop Leader, 34th Annual Madison Clinical Conference, 03/2013
Preceptor Development: Providing Effective Feedback and the Layered Learning Model, Froedtert Hospital Pharmacy Grand Rounds, 08/2013
Antimicrobial Stewardship – Fact or Fiction?, Froedtert Hospital Advanced Practice Prescriber Grand Rounds, 12/2014
Rapid Diagnostic Testing and its Impact on Antimicrobial Stewardship, Froedtert Hospital, 04/2015
Burning Questions and Answers for the Management of Urinary Tract Infections, Froedtert Hospital Advanced Practice Prescriber Grand Rounds, 06/2015
Antifungal Therapeutic Drug Monitoring, Froedtert Hospital Pharmacy Grand Rounds, 07/2015
Antimicrobial Stewardship Across the Continuum of Care: Pneumonia Update, Pharmacy Society of Wisconsin Annual Meeting, 09/2015
Antimicrobial Stewardship: Translating Theory into Practice, Froedtert Hospital Get Smart About Antibiotics Campaign, 12/2015
Procalcitonin Utilization in Lower Respiratory Tract Infections, Froedtert Hospital and the Medical College of Wisconsin Emergency Department Grand Rounds, 01/2016
Bad Bugs, No Drugs, What’s Next?, Froedtert Hospital and the Medical College of Wisconsin Medicine Grand Rounds, 03/2016
Managing Sepsis: A Fight for Survival, Pharmacy Society of Wisconsin Educational Conference, 04/2016
Beyond the Guidelines: Key Strategies for a Successful Antimicrobial Stewardship Program, Vizient Clinical Connections Summit, 09/2016
C. d$ff Happens: An Update on Risk Factors and Treatment, Greater Milwaukee College of Clinical Pharmacy, Fall Meeting, 11/2016
Powell K, Revolinski S, Daniels A, Gibble A, Huang A., A Single Center Quasi-Experimental Study to Evaluate the Impact of a Multiplex PCR System Combined with AMS Intervention on Time to Targeted Therapy in Patients with Suspected CNS Infections, ID Week, 10/2017
Antimicrobial Stewardship at the Bedside: How Nurses can Optimize Antibiotic Use, Froedtert and the Medical College of Wisconsin Nursing Grand Rounds, 06/2018
Antimicrobial Stewardship in Sepsis, Greater Milwaukee Area of Critical Care Nurses, 09/2018
Drug-Induced Nutrient Depletion, Greater Milwaukee College of Clinical Pharmacy, Fall Meeting, 11/2018
Understanding EPAs and MCW Student Assessments, Medical College of Wisconsin School of Pharmacy, 02/2019
IDentifying the Therapeutic Role of New Antimicrobials and Vaccines, Greater Milwaukee College of Clinical Pharmacy, Fall Meeting, 11/2019
 

COMMITTEE SERVICE:
Medical College of Wisconsin
03/2018 - Present Pathways Advisor for Quality and Patient Safety, Scholarly Pathway, Medical College of Wisconsin
 

EXTRAMURAL TEACHING:
Medical Student Education
05/2017 Medical College of Wisconsin, Milwaukee, WI, M4 Capstone Course: Bad Bugs, No Drugs, What’s Next?
05/2018 Medical College of Wisconsin, Green Bay, WI, Capstone Course: Bad Bugs, No Drugs, What’s Next?
 
Pharmacy Student Education
10/2012 Concordia University Wisconsin School of Pharmacy, Multiple Sclerosis
11/2013 Concordia University Wisconsin School of Pharmacy, Multiple Sclerosis
09/2014 Concordia University Wisconsin School of Pharmacy, Pneumonia – What’s New?
09/2015 Concordia University Wisconsin School of Pharmacy, Pneumonia – What’s New?
09/2017 - 09/2019 Medical College of Wisconsin School of Pharmacy, PHAR 511: Hypersensitivity
01/2018 - 03/2018 Medical College of Wisconsin School of Pharmacy, PHAR 562: Integrated Sequence: Infectious Diseases I
01/2018 - Present Medical College of Wisconsin School of Pharmacy, PHAR 562: General Antibiotic Considerations
01/2018 Medical College of Wisconsin School of Pharmacy, PHAR 562: Bacterial Microbiology
03/2018 - Present Medical College of Wisconsin School of Pharmacy, PHAR 562: Antimicrobial Stewardship
04/2018 - Present Medical College of Wisconsin School of Pharmacy, PHAR 564: Upper Respiratory Tract Infections
04/2018 Medical College of Wisconsin School of Pharmacy, PHAR 533: Infectious Diseases Case Day
04/2018 Medical College of Wisconsin School of Pharmacy, PHAR 533: Infectious Diseases Workshop – Drug Interactions and Special Populations
04/2018 - 04/2019 Medical College of Wisconsin School of Pharmacy, PHAR 564: Influenza
04/2018 - 06/2018 Medical College of Wisconsin School of Pharmacy, PHAR 564: Integrated Sequence: Infectious Diseases II
04/2018 - Present Medical College of Wisconsin School of Pharmacy, PHAR 564: Lower Respiratory Tract Infections
04/2018 - Present Medical College of Wisconsin School of Pharmacy, PHAR 564: Clostridium difficile Infection
04/2018 Medical College of Wisconsin School of Pharmacy, PHAR 533: NACDS Certificate
06/2018 Medical College of Wisconsin School of Pharmacy, PHAR 533: Mega Case Day
07/2018 - Present Medical College of Wisconsin School of Pharmacy, PHAR 640: Introductory Pharmacy Practice Experience IV
07/2018 - Present Medical College of Wisconsin School of Pharmacy, PHAR 540: Introduction to Pharmacy Practice
10/2018 - Present Medical College of Wisconsin School of Pharmacy, PHAR 541: Introductory Pharmacy Practice Experience I
10/2018 - Present Medical College of Wisconsin School of Pharmacy, PHAR 641: Introductory Pharmacy Practice Experience V
01/2019 - Present Medical College of Wisconsin School of Pharmacy, PHAR 542: Introductory Pharmacy Practice Experience II
01/2019 - Present Medical College of Wisconsin School of Pharmacy, PHAR 642: Introductory Pharmacy Practice Experience VI
03/2019 - Present Medical College of Wisconsin School of Pharmacy, PHAR 643: Introductory Pharmacy Practice Experience VII
03/2019 - Present Medical College of Wisconsin School of Pharmacy, PHAR 543: Introductory Pharmacy Practice Experience III
07/2019 - Present Medical College of Wisconsin School of Pharmacy, PHAR 740: Advanced Pharmacy Practice Experience
01/2020 - Present Medical College of Wisconsin School of Pharmacy, PHAR 675: Advanced Patient Cases Elective
 
Graduate Student Education
09/2016 Medical College of Wisconsin, Graduate School, Infectious Diseases Epidemiology: Influenza Preparedness
 
Resident and Fellow Education
09/2014 - Present Medical College of Wisconsin, Milwaukee, WI, Fellow didactic lecture: Antimicrobial Stewardship
 
Postdoctoral Fellow Education
08/2014 Medical College of Wisconsin, Milwaukee, WI, Fellow didactic lecture: Antibacterials 2 – Gram-Positives
09/2014 - Present Medical College of Wisconsin, Milwaukee, WI, Fellow didactic lecture: Antibacterials 4
 

PROGRAMMATIC DEVELOPMENTS:
 
 
Clinical Programs
10/2012 - 06/2018 Infectious Diseases/Antimicrobial Stewardship Rotation
03/2020 - 06/2020 Infectious Diseases and Academia Advanced Pharmacy Practice Experience
03/2020 - 06/2020 Virtual Introductory Pharmacy Practice Experience - Developed individualized learning plans for over 60 students completing rotation virtually due to COVID-19
 
 

EDUCATIONAL PRESENTATIONS:
09/2013 Preceptee, Preceptor, or Both? Froedtert Pharmacy Resident Introduction to Precepting Audience: Froedtert & the Medical College of Wisconsin PGY1 and PGY2 Residents
09/2014 Preceptee, Preceptor, or Both? Froedtert Pharmacy Resident Introduction to Precepting Audience: Froedtert & the Medical College of Wisconsin PGY1 and PGY2 Residents
08/2015 Outcomes Associated with Rapid Diagnosis of Bloodstream Infections Utilizing Verigene Technology Infectious Diseases Research Conference Audience: Infectious diseases providers, pharmacists, medical residents and students
09/2015 Clinical Discussion: Pharmacokinetics in Special Populations: Obesity and Critical Illness Audience: Froedtert & the Medical College of Wisconsin Pharmacy Residents
02/2016 Vancomycin Dosing in Hemodialysis Audience: Medical College of Wisconsin: department of nephrology
04/2016 Antibiotic Considerations in Head and Neck Surgery Audience: Medical College of Wisconsin: department of oral and maxillofacial surgery
04/2018 Antibiotic Considerations in Head and Neck Surgery Audience: Medical College of Wisconsin: department of oral and maxillofacial surgery

NON PEER-REVIEWED JOURNALS:
Strzelecki S. Assessing and maintaining asthma control: Pharmacists play a vital role in asthma management. J Pharm Soc Wis. March-April 2006:31-34.
Afanasveja J, Revolinski S. Stress ulcer prophylaxis in hospitalized non-ICU patients: A review of recent research and recommendations for providing stress ulcer prophylaxis to general medical and surgical patients. J Pharm Soc Wis.
Bunnell K, Revolinski S, Wainaina N. Chloroquine and hydroxychloroquine: What does the evidence say for use in COVID-19? J Pharm Soc Wis. May-June 2020: 26-30.

PEER-REVIEWED JOURNALS:
Zein Eddine SB, Cooper-Johnson K, Ericksen F, Brookes CC, Peppard WJ, Revolinski SL, Carver TW. Antibiotic duration and outcome complications for surgical site infection prevention in traumatic mandible fracture. J Surg Res. 2020;247:524-529.
Revolinski SL, Munoz-Price LS. Clostridioides difficile in transplant patients: Early diagnosis, treatment, and prevention. Curr Opin Infect Dis. 2019;32:307-313.
Revolinski SL, Huang AM, Hoefing EF. ID corner: Pharmacy preparations for epidemics. The Ebola experience. J Pharm Soc Wis. 2015;18:39-41.
Revolinski SL, Munoz-Price LS. Clostridium difficile in immunocompromised hosts: A review of epidemiology, risk factors, treatment, and prevention. Clin Infect Dis. 2019;30:2144-2153.
Revolinski S. Implementation of a clinical decision support alert for the management of Clostridium difficile infection. Antibiotics. 2015;4:667-674.
Revolinski S, Munoz-Price LS. A new perspective for an old problem: Asymptomatic Clostridium difficile colonization and implications for prevention. Infect Control Hosp Epidemiol. 2018;39:596-602.
Zepke PC, Peppard WJ, Revolinski SL. Vaccination practices in patients undergoing splenectomy secondary to traumatic injury. J Pharm Soc Wis.2017.
Foolad F, Huang AM, Nguyen CT, Colyer L, Lim M, Grieger J, Li J, Revolinski S, Mack M, Gandhi T, Wainaina JN, Eschenauer G, Patel TS, Marshall VD, Nagel J. A multicentre stewardship initiative to decrease excessive duration of antibiotic therapy for the treatment of community-acquired pneumonia. J Antimicrob Chemother. 2018; doi:10.1093/jac/dky021.

POSTERS:
Tran C, Huang A, Wainaina JN, Munoz-Price LS, Revolinski SL. Implementation of a vertical antimicrobial stewardship intervention for patients colonized with Clostridium difficile. ID Week. 2018.
Strzelecki S, Yerondopoulos M, Windisch P. Outcomes assessment of an inpatient pharmacist-managed warfarin protocol in an academic medical center: comparative analysis of pharmacist-managed and physician-managed warfarin therapy. American Society of Health-System Pharmacists Midyear Clinical Meeting. 2006.
Long A, Daniels A, Revolinski S. Optimization of antibiotic time-outs through pharmacist-led completion. Pharmacy Society of Wisconsin – Wisconsin Pharmacy Residency Conference. 2020.
Bishop S, Revolinski S, Dekarske B, Wainaina JN. Evaluation of clinical decision support for antibiotic time outs. Vizient University Health System Consortium Annual Meeting. 2017.
Worzella S, Revolinski S, Dang C. Characterizing initiation of antibiotic treatment of asymptomatic bacteriuria in the emergency department. American Society of Health-System Pharmacists Midyear Clinical Meeting. 2015.
Koenig B, Revolinski S, Achey T. Characterization of a longitudinal advanced pharmacy practice experience (APPE) program at an academic medical center. American Society of Health-System Pharmacists Midyear Clinical Meeting. 2014.
Cook G, Revolinski S, Gibble A, Wainaina JN, Windham S, Stromich A, Huang A. Single center, quasi-experimental study to evaluate the impact of a multifaceted antimicrobial stewardship intervention in patients with asymptomatic bacteriuria and candiduria. Vizient University Health System Consortium Annual Meeting. 2017.
Tran C, Huang A, Wainaina JN, Munoz-Price LS, Revolinski S. Implementation of a vertical antimicrobial stewardship intervention for patients colonized with Clostridium difficile. Vizient University Health System Consortium Annual Meeting. 2017.
Revolinski S, Patterson C, Daniels A, Wainaina N. Characterizing utilization and cost of ertapenem and daptomycin in the outpatient setting at an academic medical center. Interscience Conference on Antimicrobial Agents and Chemotherapy Poster Presentation, 54th Annual Meeting. September 2015.
Olson K, Revolinski S, Daniels A, Wainaina JN, Hoyt J, Huang A. A single center quasi-experimental study to evaluate the impact of utilizing rapid diagnostic technology to detect methicillin-resistant Staphylococcus aureus in respiratory culture samples. ID Week. 2018.
Achey TS, Huang A, Schulz S, Stanton M, Dow J, Wainaina N, Umpierrez de Reguero A, Revolinski S. Evaluation of procalcitonin-guided antimicrobial therapy in the treatment of lower respiratory tract infections. University HealthSystem Consortium Pharmacy Council Meeting. 2014.
Chan P, Daniels A, Wainaina N, Stromich J, Revolinski S. Outpatient parenteral antimicrobial therapy stewardship review and intervention. University HealthSystem Consortium Pharmacy Council Meeting. 2015.
Preedit J, Huang A, Buchan B, Biggs A, Herrmann D, Daniels A, Revolinski S. Pharmacist intervention using MRSA/MSSA nucleic acid amplification test on respiratory specimens in intensive care unit patients. Vizient University Health System Consortium Annual Meeting. 2017.
Gibble A, Revolinski S, Wainaina JN, Huang A. Impact of antimicrobial stewardship pharmacist intervention on the management of infections caused by organisms harboring chromosomal AmpC beta-lactamases. Making a Difference in Infectious Diseases Pharmacotherapy. 2016.
Beaupre N, Feldman R, Revolinski S, Powell K, Huang A, Case L, Wainaina JN, Theobald J. Impact of implementation of a skin and soft tissue infection treatment guideline in the emergency department. Vizient University Health System Consortium Annual Meeting. 2017.
McGurty E, Huang A, Gibble A, Aschenbrenner E, Daniels A, McCoy C, Revolinski S, Rhoades M. Evaluation of a pharmacist-driven therapeutic drug monitoring program for triazole antifungals. Vizient University Health System Consortium Annual Meeting. 2017.
Revolinski S, Wainaina NJ, Graham MB, Munoz-Price LS. Vertical antimicrobial stewardship to reduce C. difficile colitis in colonized patients. The Society for Healthcare Epidemiology of America Spring 2016 Conference. 2016.
Aslam A, Pertzborn M, Revolinski S. Assessing fluoroquinolone prescribing and clinical outcomes in ambulatory care settings. American Society of Health-System Pharmacists Midyear Clinical Meeting. 2019
Jeon H, Dang C, Revolinski S. Single dose vancomycin in patients discharged from the emergency department. 25th Annual Emergency Medicine Research Forum. 2017. Revolinski SL, Wainaina NJ, Huang AM, Graham MB, Ledeboer NA, Peppard W, Tarima S, Munoz-Price SL. Impact of clinical pharmacist intervention on the effectiveness of a rapid diagnostic test for gram-positive bacteria. ID Week. 2016.
Wollenziehn A, Lorge A, Revolinski S, Huang A. Evaluation of a risk stratification guideline for the treatment of neutropenic fever for oncology patients. ID Week. 2017.
Olson K, Huang A, Revolinski S, Daniels A, Wainaina JN, Hoyt J. A single center quasi-experimental study to evaluate the impact of utilization of rapid diagnostic technology to detect methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus in respiratory culture samples. Vizient University Health System Consortium Annual Meeting. 2017.
Picone MF, Revolinski SL. Clinical outcomes associated with use of moxifloxacin in Stenotrophomonas maltophilia infection: A case series. Making a Difference in Infectious Diseases Pharmacotherapy. 2016.
Revolinski S, Zechlinski A, Karpinski T, Brummond P, Achey TA, Fraser B. Best Practices Award in Health-System Pharmacy: Expanding pharmacy practice through the utilization of longitudinal advanced pharmacy practice experience students. American Society of Health-System Pharmacists Midyear Clinical Meeting. 2015.
Gibble A, Feih J, Fontana L, Revolinski S, Huang A. Analysis of the safety and efficacy of a colistin dosing guideline in the management of infections caused by multi-drug resistant gram-negative organisms. ID Week. 2016. Powell K, Huang A, Revolinski S. Impact of pharmacist intervention on compliance with a Clostridium difficile treatment bundle. ID Week. 2016.
Gibble AM, Revolinski S, Huang A, Ledeboer NA, Graham MB, Wainaina NJ, Munoz-Price LS. Evaluation of rapid diagnostic technology and pharmacist notification in gram-negative bloodstream infections using time dependent variables. ASM Microbe. 2016.
Revolinski S, Wainaina NJ, Graham MB, Munoz-Price LS. Antibiotics for Clostridium difficile infection: Impact of drug selection on treatment outcomes. ASM Microbe. 2016.
Bertolaccini CM, Konkol J, Revolinski SL. Antimicrobial stewardship clinical decision support: comparison of functionality within the electronic medical record versus third party software. University HealthSystem Consortium Pharmacy Council Meeting. 2015.
Revolinski S, Cowell J, Daniels A, Peppard W, Huang A. Implementation of clinical pharmacist-driven interventions for positive blood culture results. American College of Clinical Pharmacy Virtual Poster Symposium. May 2015.
Revolinski S, Huang A, Juul J. Impact of an antimicrobial stewardship team on the management of enterococcal urinary tract infections and asymptomatic bacteriuria. Interscience Conference on Antimicrobial Agents and Chemotherapy Poster Presentation, 54th Annual Meeting. September 2015.
Revolinski S, Huang A, Peppard W, Ledeboer N. Outcomes utilizing rapid diagnostic technology (RDT) coupled with pharmacist intervention in patients with gram-positive bloodstream infections (BSI). European Society of Clinical Microbiology and Infectious Diseases. April 2015.
McGurty E, Mercado-Schoessow H, Misustin S, Eberle D, Daniels A, Revolinski S. Risk factors for colonization with multidrug resistant organisms in patients undergoing pancreaticoduodenectomy. American Society of Health-System Pharmacists Midyear Clinical Meeting. 2015.
Laehn S, Revolinski S, Wainaina N, Huang A. Methicillin-resistant Staphylococcus aureus risk stratification clinical tool development. University HealthSystem Consortium Pharmacy Council Meeting. 2015.
McCoy C, Bialkowski K, Revolinski S, Smith H, Karczewski C. Stress ulcer prophylaxis: Assessment of prescribing in critically ill patients at transitions of care. University HealthSystem Consortium Pharmacy Council Meeting. 2012.
Revolinski SL, Cowell JM, Peppard WJ, Huang AM. Outcomes utilizing pharmacist intervention and rapid molecular diagnostic technology in patients with gram-positive bloodstream infections. Interscience Conference on Antimicrobial Agents and Chemotherapy Poster Presentation, 54th Annual Meeting. 2014.
DeGrote J, Revolinski S, Daniels A, Huang AM. Evaluation of extended infusion piperacillin/tazobactam with an initial bolus over 30 minutes. Interscience Conference on Antimicrobial Agents and Chemotherapy Poster Presentation, 54th Annual Meeting. 2014.
Van Rossum B, Dow JD, Konkol JP, Audley T, Stanton M, Bialkowski K, Simmelink C, Revolinski S. Evaluation of alternative alerts as a tool for antimicrobial stewardship. American College of Clinical Pharmacy Annual Meeting. 2014.
Gibble A, Revolinski S, Huang A, Daniels A, Horsman S, Dow J. Outcomes associated with the utilization of rapid diagnostic technology and pharmacist intervention in the management of gram-negative bacteremia. University HealthSystem Consortium Pharmacy Council Meeting. 2014.
Strzelecki S, Yerondopoulos M, Windisch P. Outcomes assessment of an inpatient pharmacist-managed warfarin protocol in an academic medical center: comparative analysis of pharmacist-managed and physician-managed warfarin therapy. University HealthSystem Consortium Pharmacy Advisory Council Meeting. 2006
Olley P, Revolinski S, Dow J, Smith H, Wagner A. Clostridium difficile treatment utilization review at an academic medical center. University HealthSystem Consortium Pharmacy Council Meeting. 2013. Shah P, Dow J, Graham MB, Revolinski S. Evaluation of vancomycin and linezolid prescribing based on methicillin-resistant Staphylococcus aureus risk assessment. University HealthSystem Consortium Pharmacy Council Meeting. 2012.
Peppard W, Eberle D, Milia D, Revolinski S, Weigelt J. Preoperative ertapenem restriction for emergent exploratory laparotomy demonstrates cost savings but does not adversely affect surgical site infection rate. Surgical Infection Society. April 2015.
Gibble A, Revolinski S, Huang A, Ledeboer N. Outcomes associated with the utilization of rapid diagnostic technology and pharmacist intervention in the management of gram-negative bacteremia. Interscience Conference on Antimicrobial Agents and Chemotherapy Poster Presentation, 54th Annual Meeting. September 2015.
Revolinski S, Wainaina JN. Successful implementation of a restriction process for a highly utilized antimicrobial. Vizient Clinical Connections Summit. 2017.
Feldman R, Huang A, Revolinski S, Dang C. Implementation and evaluation of a guideline for the treatment of community acquired pneumonia with risks for multidrug resistant organisms. University HealthSystem Consortium Pharmacy Council Meeting. 2014
Novak A, Revolinski S, Daniels A, Gibble A, Powell K. Characterizing use of cefepime in preparation for implementing an antibiotics time out process. American Society of Health-System Pharmacists Midyear Clinical Meeting. 2017.